Regulatory

Latest News

FDA Approves New Administration Methods for SK Life Science’s Xcorpi for Adults with Partial-Onset Seizures
FDA Approves New Administration Methods for SK Life Science’s Xcorpi for Adults with Partial-Onset Seizures

April 11th 2024

New methods allow the antiseizure treatment to be crushed and mixed with water for oral suspension or for use through a nasogastric tube.

FDA Approves AstraZeneca’s Fasenra as Add-On Maintenance Therapy for Children Aged 6 to 11 with Severe Asthma
FDA Approves AstraZeneca’s Fasenra as Add-On Maintenance Therapy for Children Aged 6 to 11 with Severe Asthma

April 11th 2024

Philips Respironics Finalizes Consent Decree Regarding Business Operations in the US with Department of Justice, FDA
Philips Respironics Finalizes Consent Decree Regarding Business Operations in the US with Department of Justice, FDA

April 10th 2024

Image credit: gamjai | stock.adobe.com
FDA Approves Expanded Indication for Dovato to Include Adolescent Patients with HIV

April 8th 2024

FDA Issues Complete Response Letter to Supernus for SPN-830, a Potential Treatment for Motor Fluctuations in Parkinson Disease
FDA Issues Complete Response Letter to Supernus for SPN-830, a Potential Treatment for Motor Fluctuations in Parkinson Disease

April 8th 2024

More News